Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $242,270 | 157 | 92.3% |
| Travel and Lodging | $6,999 | 47 | 2.7% |
| Consulting Fee | $6,888 | 3 | 2.6% |
| Food and Beverage | $6,356 | 114 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91,687 | 103 | $0 (2022) |
| Lilly USA, LLC | $87,558 | 93 | $0 (2022) |
| Amarin Pharma Inc. | $41,954 | 43 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $40,462 | 53 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $259.27 | 9 | $0 (2021) |
| Novo Nordisk Inc | $152.06 | 3 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $122.57 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $109.61 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $62.77 | 4 | $0 (2019) |
| PFIZER INC. | $38.58 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $23,899 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,619) |
| 2021 | $66,153 | 75 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30,004) |
| 2020 | $90,745 | 103 | Lilly USA, LLC ($39,861) |
| 2019 | $81,511 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($35,600) |
| 2018 | $204.17 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($121.36) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 08/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 07/12/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $520.00 | General |
| Category: Diabetes | ||||||
| 06/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 05/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $167.31 | General |
| Category: DIABETES | ||||||
| 05/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $18.72 | General |
| Category: DIABETES | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $170.82 | General |
| Category: DIABETES | ||||||
| 04/27/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $79.70 | General |
| Category: DIABETES | ||||||
| 04/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 04/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $102.40 | General |
| Category: DIABETES | ||||||
| 04/18/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 04/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.97 | General |
| Category: DIABETES | ||||||
| 04/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.97 | General |
| Category: DIABETES | ||||||
| 04/04/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,560.00 | General |
| Category: Diabetes | ||||||
| 03/30/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 03/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 03/25/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 03/04/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 02/18/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 12/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: DIABETES | ||||||
| 12/09/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 587 | 701 | $121,703 | $40,227 |
| 2021 | 10 | 793 | 989 | $186,456 | $63,525 |
| 2020 | 10 | 757 | 849 | $160,389 | $41,737 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 346 | $58,820 | $26,671 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $16,200 | $6,429 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 12 | 12 | $13,080 | $1,582 | 12.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 25 | 25 | $12,645 | $1,313 | 10.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 114 | 124 | $10,788 | $1,214 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $2,280 | $1,100 | 48.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 81 | 104 | $6,240 | $1,000 | 16.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $1,650 | $918.52 | 55.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 301 | 467 | $79,390 | $41,834 | 52.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 80 | 80 | $21,600 | $9,144 | 42.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 20 | 20 | $21,160 | $2,850 | 13.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 54 | 54 | $26,295 | $2,775 | 10.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 203 | 228 | $19,836 | $2,329 | 11.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $2,990 | $1,810 | 60.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 54 | $6,480 | $1,717 | 26.5% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2021 | 13 | 13 | $4,615 | $608.19 | 13.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 29 | 30 | $1,800 | $281.59 | 15.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 13 | 13 | $1,950 | $125.73 | 6.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 15 | 17 | $340.00 | $51.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 185 | $31,450 | $14,212 | 45.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 183 | 225 | $27,000 | $9,132 | 33.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 50 | 50 | $13,500 | $5,706 | 42.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 76 | 76 | $35,508 | $3,844 | 10.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 27 | 27 | $28,150 | $3,808 | 13.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 159 | 173 | $15,051 | $1,893 | 12.6% |
About Dr. Woodrow Corey, MD
Dr. Woodrow Corey, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700844172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Woodrow Corey, MD has received a total of $262,512 in payments from pharmaceutical and medical device companies, with $23,899 received in 2022. These payments were reported across 321 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($242,270).
As a Medicare-enrolled provider, Corey has provided services to 2,137 Medicare beneficiaries, totaling 2,539 services with total Medicare billing of $145,490. Data is available for 3 years (2020–2022), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Indianapolis, IN
- Active Since 05/03/2006
- Last Updated 08/11/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700844172
Products in Payments
- JARDIANCE (Drug) $168,778
- Vascepa (Drug) $41,954
- FARXIGA (Drug) $40,399
- TRULICITY (Drug) $6,413
- INVOKANA (Drug) $224.17
- XARELTO (Drug) $157.67
- LEQVIO (Drug) $96.34
- PRALUENT (Drug) $49.03
- BRILINTA (Drug) $44.18
- CHANTIX (Drug) $38.58
- LifeVest (Device) $19.00
- Repatha (Biological) $17.29
- PRADAXA (Drug) $16.90
- PRALUENT (Biological) $16.89
- Corlanor (Drug) $14.89
- ELIQUIS (Drug) $13.74
- MULTAQ (Drug) $13.74
- ENTRESTO (Drug) $13.27
- Ozempic (Drug) $12.34
- PRALUENT ALIROCUMAB INJECTION (Biological) $12.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
Rafat Abonour, Md, MD
Internal Medicine — Payments: $833,709
David Batt, Md, MD
Internal Medicine — Payments: $682,018
Ashwin Ravichandran, Md, MD
Internal Medicine — Payments: $398,583
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
James Trippi, Md, MD
Internal Medicine — Payments: $280,481